Human Platelet Lysate Improves Bone Forming Potential of Human Progenitor Cells Expanded in Microcarrier-Based Dynamic Culture.

Gupta, Priyanka; Hall, Gabriella Nilsson; Geris, Liesbet; Luyten, Frank P.; Papantoniou, Ioannis

doi:10.1002/sctm.18-0216

Article (Scientific journals)

Human Platelet Lysate Improves Bone Forming Potential of Human Progenitor Cells Expanded in Microcarrier-Based Dynamic Culture.

Gupta, Priyanka; Hall, Gabriella Nilsson; Geris, Liesbet et al.

2019 • In Stem Cells Translational Medicine

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/237854

DOI
10.1002/sctm.18-0216

PubMed
31038850

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

sctm. Gupta 18-0216.pdf

Publisher postprint (4.04 MB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Abstract :

[en] Xenogeneic-free media are required for translating advanced therapeutic medicinal products to the clinics. In addition, process efficiency is crucial for ensuring cost efficiency, especially when considering large-scale production of mesenchymal stem cells (MSCs). Human platelet lysate (HPL) has been increasingly adopted as an alternative for fetal bovine serum (FBS) for MSCs. However, its therapeutic and regenerative potential in vivo is largely unexplored. Herein, we compare the effects of FBS and HPL supplementation for a scalable, microcarrier-based dynamic expansion of human periosteum-derived cells (hPDCs) while assessing their bone forming capacity by subcutaneous implantation in small animal model. We observed that HPL resulted in faster cell proliferation with a total fold increase of 5.2 +/- 0.61 in comparison to 2.7 +/- 02.22-fold in FBS. Cell viability and trilineage differentiation capability were maintained by HPL, although a suppression of adipogenic differentiation potential was observed. Differences in mRNA expression profiles were also observed between the two on several markers. When implanted, we observed a significant difference between the bone forming capacity of cells expanded in FBS and HPL, with HPL supplementation resulting in almost three times more mineralized tissue within calcium phosphate scaffolds. FBS-expanded cells resulted in a fibrous tissue structure, whereas HPL resulted in mineralized tissue formation, which can be classified as newly formed bone, verified by muCT and histological analysis. We also observed the presence of blood vessels in our explants. In conclusion, we suggest that replacing FBS with HPL in bioreactor-based expansion of hPDCs is an optimal solution that increases expansion efficiency along with promoting bone forming capacity of these cells. Stem Cells Translational Medicine 2019.

Disciplines :

Engineering, computing & technology: Multidisciplinary, general & others

Author, co-author :

Gupta, Priyanka

Hall, Gabriella Nilsson

Geris, Liesbet ; Université de Liège - ULiège > Département d'aérospatiale et mécanique > Génie biomécanique

Luyten, Frank P.

Papantoniou, Ioannis

Language :

English

Title :

Human Platelet Lysate Improves Bone Forming Potential of Human Progenitor Cells Expanded in Microcarrier-Based Dynamic Culture.

Publication date :

2019

Journal title :

Stem Cells Translational Medicine

ISSN :

2157-6564

eISSN :

2157-6580

Publisher :

Wiley-Blackwell, United Kingdom

Peer reviewed :

Peer Reviewed verified by ORBi

Commentary :

Available on ORBi :

since 02 July 2019

Statistics

Number of views

90 (2 by ULiège)

Number of downloads

81 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Tan KY, Reuveny S, Oh SKW. Recent advances in serum-free microcarrier expansion of mesenchymal stromal cells: Parameters to be optimized. Biochem Biophys Res Commun 2016;473:769–773.
Lambrechts T, Papantoniou I, Rice B et al. Large-scale progenitor cell expansion for multiple donors in a monitored hollow fibre bioreactor. Cytotherapy 2016;18:1219–1233.
Wakitani S, Imoto K, Yamamoto T et al. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr Cartil 2002;10:199–206.
Doucet C, Ernou I, Zhang Y et al. Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 2005;205:228–236.
Müller AM, Davenport M, Verrier S et al. Platelet lysate as a serum substitute for 2D static and 3D perfusion culture of stromal vascular fraction cells from human adipose tissue. Tissue Eng Part A 2009;15:869–875.
Strunk D, Lozano M, Marks D et al. International forum on Gmp-grade human platelet lysate for cell propagation: Summary. Vox Sang 2018;113:80–87.
Azouna NB, Jenhani F, Regaya Z et al. Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: Comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Stem Cell Res Ther 2012;3:6.
Capelli C, Domenghini M, Borleri G et al. Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant 2007;40:785–791.
Fazzina R, Iudicone P, Fioravanti D et al. Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues. Stem Cell Res Ther 2016;7:122.
Lange C, Cakiroglu F, Spiess AN et al. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 2007;213:18–26.
Matthyssen S, Dhubhghaill SN, Van Gerwen V et al. Xeno-free cultivation of mesenchymal stem cells from the corneal stroma. Invest Ophthalmol Vis Sci 2017;58:2659–2665.
Reinisch A, Bartmann C, Rohde E et al. Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen Med 2007;2:371–382.
Schallmoser K, Rohde E, Reinisch A et al. Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods 2008;14:185–196.
Galeano-Garces C, Camilleri ET, Riester SM et al. Molecular validation of chondrogenic differentiation and hypoxia responsiveness of platelet-lysate expanded adipose tissue-derived human mesenchymal stromal cells. Cartilage 2017;8:283–299.
Hassan G, Bahjat M, Kasem I et al. Platelet lysate induces chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells. Cell Mol Biol Lett 2018;23:11.
Jonsdottir-Buch SM, Lieder R, Sigurjonsson OE. Platelet lysates produced from expired platelet concentrates support growth and osteogenic differentiation of mesenchymal stem cells. PLoS One 2013;8:e68984.
Salvade A, Mina PD, Gaddi D et al. Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. Tissue Eng Part C Methods 2009;16:201–214.
Petry F, Smith JR, Leber J et al. Manufacturing of human umbilical cord mesenchymal stromal cells on microcarriers in a dynamic system for clinical use. Stem Cells Int 2016;2016:1–12.
Heathman TR, Stolzing A, Fabian C et al. Scalability and process transfer of mesenchymal stromal cell production from monolayer to microcarrier culture using human platelet lysate. Cytotherapy 2016;18:523–535.
Soure AM, Fernandes-Platzgummer A, Moreira F et al. Integrated culture platform based on a human platelet lysate supplement for the isolation and scalable manufacturing of umbilical cord matrix-derived mesenchymal stem/stromal cells. J Tissue Eng Regen Med 2017;11:1630–1640.
Gadelorge M, Bourdens M, Espagnolle N et al. Clinical-scale expansion of adipose-derived stromal cells starting from stromal vascular fraction in a single-use bioreactor: Proof of concept for autologous applications. J Tissue Eng Regen Med 2018;12:129–141.
Lawson T, Kehoe DE, Schnitzler AC et al. Process development for expansion of human mesenchymal stromal cells in a 50L single-use stirred tank bioreactor. Biochem Eng J 2017;120:49–62.
Rafiq QA, Ruck S, Hanga MP et al. Qualitative and quantitative demonstration of bead-to-bead transfer with bone marrow-derived human mesenchymal stem cells on microcarriers: Utilising the phenomenon to improve culture performance. Biochem Eng J 2018;135:11–21.
Bellio MA, Khan A. 74—Expanding mesenchymal stem cells with platelet lysate vs FBS increases bioreactor efficiency but alters cytokine prolife. Cytotherapy 2018;20:S29.
Haack-Sørensen M, Juhl M, Follin B et al. Development of large-scale manufacturing of adipose-derived stromal cells for clinical applications using bioreactors and human platelet lysate. Scand J Clin Lab Invest 2018;78:1–8.
Mizukami A, de Abreu Neto MS, Moreira F et al. A fully-closed and automated hollow fiber bioreactor for clinical-grade manufacturing of human mesenchymal stem/stromal cells. Stem Cell Rev Rep 2018;14:141–143.
Colnot C. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res 2009;24:274–282.
De Lageneste OD, Julien A, Abou-Khalil R et al. Periosteum contains skeletal stem cells with high bone regenerative potential controlled by Periostin. 2018;9:773.
Zhang X, Awad HA, O'Keefe RJ et al. A perspective: Engineering periosteum for structural bone graft healing. Clin Orthop Relat Res 2008;466:1777–1787.
Bolander J, Chai YC, Geris L et al. Early BMP, Wnt and Ca2+/PKC pathway activation predicts the bone forming capacity of periosteal cells in combination with calcium phosphates. 2016;86:106–118.
De Bari C, Dell'Accio F, Luyten FP. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheumatol 2001;44:85–95.
Bolander J, Ji W, Leijten J et al. Healing of a large long-bone defect through serum-free in vitro priming of human periosteum-derived cells. 2017;8:758–772.
Eyckmans J, Roberts SJ, Bolander J et al. Mapping calcium phosphate activated gene networks as a strategy for targeted osteoinduction of human progenitors. 2013;34:4612–4621.
Bolander J, Ji W, Geris L et al. The combined mechanism of bone morphogenetic protein-and calcium phosphate-induced skeletal tissue formation by human periosteum derived cells. 2016;30:11–25.
Roberts SJ, van Gastel N, Carmeliet G et al. Uncovering the periosteum for skeletal regeneration: The stem cell that lies beneath. Bone 2015;70:10–18.
Gupta P, Geris L, Luyten FP et al. An integrated bioprocess for the expansion and chondrogenic priming of human periosteum-derived progenitor cells in suspension bioreactors. Biotechnol J 2018;13. https://doi.org/10.1002/biot.201700087.
Lambrechts T, Papantoniou I, Viazzi S et al. Evaluation of a monitored multiplate bioreactor for large-scale expansion of human periosteum derived stem cells for bone tissue engineering applications. Biochem Eng J 2016;108:58–68.
Sonnaert M, Papantoniou I, Bloemen V et al. Human periosteal-derived cell expansion in a perfusion bioreactor system: Proliferation, differentiation and extracellular matrix formation. J Tissue Eng Regen Med 2017;11:519–530.
Papantoniou I, Guyot Y, Sonnaert M et al. Spatial optimization in perfusion bioreactors improves bone tissue-engineered construct quality attributes. Biotechnol Bioeng 2014;111:2560–2570.
Papantoniou I, Sonnaert M, Lambrechts T et al. Analysis of gene expression signatures for osteogenic 3D perfusion-bioreactor cell cultures based on a multifactorial DoE approach. Processes 2014;2:639–657.
Xia W, Li H, Wang Z et al. Human platelet lysate supports ex vivo expansion and enhances osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Cell Biol Int 2011;35:639–643.
Chevallier N, Anagnostou F, Zilber S et al. Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials 2010;31:270–278.
Nemoto E, Ebe Y, Kanaya S et al. Wnt5a signaling is a substantial constituent in bone morphogenetic protein-2-mediated osteoblastogenesis. 2012;422:627–632.
De Bari C, Dell'Accio F, Vanlauwe J et al. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 2006;54:1209–1221.
Papantoniou I, Lambrechts T, J-MJCGTI A. Bioprocess engineering strategies for autologous human MSC-based therapies: One size does not fit all. 2017;3:469–482.
Rafiq QA, Brosnan KM, Coopman K et al. Culture of human mesenchymal stem cells on microcarriers in a 5 l stirred-tank bioreactor. Biotechnol Lett 2013;35:1233–1245.
Rafiq QA, Coopman K, Nienow AW et al. Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactors. Biotechnol J 2016;11:473–486.
Sart S, Schneider Y-J, Agathos SN. Influence of culture parameters on ear mesenchymal stem cells expanded on microcarriers. J Biotechnol 2010;150:149–160.
Crespo-Diaz R, Behfar A, Butler GW et al. Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplant 2011;20:797–812.
Santos F, Andrade PZ, Abecasis MM et al. Toward a clinical-grade expansion of mesenchymal stem cells from human sources: A microcarrier-based culture system under xeno-free conditions. 2011;17:1201–1210.
Legrand C, Bour J, Jacob C et al. Lactate dehydrogenase (LDH) activity of the number of dead cells in the medium of cultured eukaryotic cells as marker. 1992;25:231–243.
Wagner A, Marc A, Engasser J et al. The use of lactate dehydrogenase (LDH) release kinetics for the evaluation of death and growth of mammalian cells in perfusion reactors. 1992;39:320–326.
Sart S, Agathos SN, Li Y. Process engineering of stem cell metabolism for large scale expansion and differentiation in bioreactors. Biochem Eng J 2014;84:74–82.
Ode A, Kopf J, Kurtz A et al. CD73 and CD29 concurrently mediate the mechanically induced decrease of migratory capacity of mesenchymal stromal cells. Eur Cell Mater 2011;24:26–42.
Ode A, Schoon J, Kurtz A et al. CD73/5′-ecto-nucleotidase acts as a regulatory factor in osteo−/chondrogenic differentiation of mechanically stimulated mesenchymal stromal cells. Eur Cell Mater 2013;25:37–47.
Chen X, Shao H, Zhi Y et al. CD73 pathway contributes to the immunosuppressive ability of mesenchymal stem cells in intraocular autoimmune responses. 2016;25:337–346.
Kerkelä E, Laitinen A, Räbinä J et al. Adenosinergic Immunosuppression by human mesenchymal stromal cells requires co-operation with T cells. Stem Cells 2016;34:781–790.
Kawakami Y, Rodriguez-León J, Belmonte JCI. The role of TGFβs and Sox9 during limb chondrogenesis. Curr Opin Cell Biol 2006;18:723–729.
Bell DM, Leung KKH, Wheatley SC et al. SOX9 directly regulates the type-ll collagen gene. Nat Genet 1997;16:174–178.
Han Y, Lefebvre V. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol Cell Biol 2008;28:4999–5013.
Yasuda H, Oh C-D, Chen D et al. A novel regulatory mechanism of type II collagen expression via a SOX9-dependent enhancer in intron 6. J Biol Chem 2016;292:528–538. https://doi.org/10.1074/jbc.M116.758425.
Vega SL, Kwon MY, Song KH et al. Combinatorial hydrogels with biochemical gradients for screening 3D cellular microenvironments. 2018;9:614.
Aubin JEJRE, Disorders M. Regulation of osteoblast formation and function. Rev Endocr Metab Disord 2001;2:81–94.
Castrén E, Sillat T, Oja S et al. Osteogenic differentiation of mesenchymal stromal cells in two-dimensional and three-dimensional cultures without animal serum. Stem Cell Res Ther 2015;6:167.
Horn P, Bokermann G, Cholewa D et al. Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells. Cytotherapy 2010;12:888–898.
Roberts SJ, Geris L, Kerckhofs G et al. The combined bone forming capacity of human periosteal derived cells and calcium phosphates. Biomaterials 2011;32:4393–4405.
Takada I, Kouzmenko AP, Kato S. Wnt and PPARγ signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol 2009;5:442–447.
Boland GM, Perkins G, Hall DJ et al. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 2004;93:1210–1230.
Chen Z, Wu C, Gu W et al. Osteogenic differentiation of bone marrow MSCs by β-tricalcium phosphate stimulating macrophages via BMP2 signalling pathway. Biomaterials 2014;35:1507–1518.
Gibson JD, O'Sullivan MB, Alaee F et al. Regeneration of articular cartilage by human ESC-derived mesenchymal progenitors treated sequentially with BMP-2 and Wnt5a. Stem Cells Translational Medicine 2017;6:40–50.
Ling L, Nurcombe V, Cool SM. Wnt signaling controls the fate of mesenchymal stem cells. Gene 2009;433:1–7.
Reis M, McDonald D, Nicholson L et al. Global phenotypic characterisation of human platelet lysate expanded MSCs by high-throughput flow cytometry. Sci Rep 2018;8:3907.
Heathman TR, Stolzing A, Fabian C et al. Serum-free process development: Improving the yield and consistency of human mesenchymal stromal cell production. Cytotherapy 2015;17:1524–1535.
Salzig D, Leber J, Merkewitz K et al. Attachment, growth, and detachment of human mesenchymal stem cells in a chemically defined medium. Stem Cells Int 2016;2016:1–10.
Leber J, Barekzai J, Blumenstock M et al. Microcarrier choice and bead-to-bead transfer for human mesenchymal stem cells in serum-containing and chemically defined media. Process Biochem 2017;59:255–265.